Standard and Expanded Series Patch Testing Update by the Spanish Contact Dermatitis and Skin Allergy Research Group (GEIDAC)ACTAS DERMO-SIFILIOGRAFICASIF2.82024-07-010OAAI
Targeting obesity-related cancer progression with novel leptin receptor antagonistsCANCER RESEARCHIF16.62017-07-010PRE
Novel adjuvant therapy for obesity-related cancersCANCER EPIDEMIOLOGY BIOMARKERS & PREVENTIONIF3.42017-02-050PRE
Leptin-induced transphosphorylation of vascular endothelial growth factor receptor increases Notch and stimulates endothelial cell angiogenic transformationINTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGYIF2.82016-10-0134OAAI
Leptin induces early onset and aggressiveness of pancreatic cancerCANCER RESEARCHIF16.62016-07-150PRE
IONP-LPrA2 and PEG-LPrA2 therapies for triple negative breast cancerCANCER RESEARCHIF16.62016-07-150PRE
Leptin modulation of PCSC, HDAC, and microRNA in pancreatic adenocarcinomaCANCER RESEARCHIF16.62016-07-152PRE
PEG-LPrA2 is a non-toxic adjuvant for triple negative breast cancerCANCER RESEARCHIF16.62016-07-150PRE
Targeting the obesity/leptin link to TNBC: A breast cancer disparity problemCANCER EPIDEMIOLOGY BIOMARKERS & PREVENTIONIF3.42016-03-011PRE
A new approach to targeted therapy for obesity-related pancreatic adenocarcinomaCANCER EPIDEMIOLOGY BIOMARKERS & PREVENTIONIF3.42016-03-011PRE
Development of an innovative treatment for obesity-related triple-negative breast cancerCANCER EPIDEMIOLOGY BIOMARKERS & PREVENTIONIF3.42016-03-010PRE
Leptin affects proliferation, stem cells and chemotherapeutic treatment outcome of pancreatic cancer: A link to health disparityCANCER EPIDEMIOLOGY BIOMARKERS & PREVENTIONIF3.42016-03-012PRE
Tackling obesity-related cancer health disparity, new inhibitors of leptin signalingCANCER EPIDEMIOLOGY BIOMARKERS & PREVENTIONIF3.42016-03-010PRE
Obesity induced leptin-tumor stroma crosstalk in breast cancer: A link to cancer health disparityCANCER EPIDEMIOLOGY BIOMARKERS & PREVENTIONIF3.42016-03-010PRE
NILCO: A marker for obesity-related endometrial cancer in African American womenCANCER EPIDEMIOLOGY BIOMARKERS & PREVENTIONIF3.42016-03-010PRE
Iron oxide nanoparticle-leptin receptor antagonist: A novel targeted adjuvant therapy for triple negative breast cancerCANCER RESEARCHIF16.62015-08-013PRE